Chromium and Semaglutide

Supplement–drug interaction evidence from the TruthStack database.

SeverityHIGH
Evidence TierModerate
Interaction TypePHARMACODYNAMIC RISK
MechanismPHARMACODYNAMIC
Last Reviewed2026-02-16

Summary

Both GLP-1 agonists and chromium may lower blood glucose. Combined use may increase hypoglycemia risk. Literature flags additive glucose-lowering effect. Monitor blood glucose and discuss with your prescriber or pharmacist.

API Reference

GET https://api.truthstack.co/v1/check?c1=Chromium&c2=Semaglutide

Open, unauthenticated. Returns JSON. Developer documentation

Related Interactions

What this page is and is not. TruthStack is an informational reference database that describes published pharmacological findings. It does not provide medical advice, diagnosis, or treatment recommendations. The information on this page reflects flags in our database and should not replace consultation with a qualified healthcare provider. Always discuss supplement-drug combinations with your prescriber or pharmacist.